应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01228 北海康成-B
休市中 03-20 16:08:47
2.660
+0.150
+5.98%
最高
2.660
最低
2.500
成交量
77.80万
今开
2.540
昨收
2.510
日振幅
6.37%
总市值
15.83亿
流通市值
15.83亿
总股本
5.95亿
成交额
199.40万
换手率
0.13%
流通股本
5.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 北海康成-B(01228)午后涨超4% 公司完成向药明生物子公司配售股份
智通财经 · 03-13
港股异动 | 北海康成-B(01228)午后涨超4% 公司完成向药明生物子公司配售股份
北海康成-B(01228)完成发行合共8403.36万股认购股份
智通财经 · 03-11
北海康成-B(01228)完成发行合共8403.36万股认购股份
北海康成-B盘中异动 大幅下跌6.99%报2.530港元
市场透视 · 03-09
北海康成-B盘中异动 大幅下跌6.99%报2.530港元
北海康成-B(01228)更新2月股份变动月报表,股本增至511,252,234股
公告速递 · 03-05
北海康成-B(01228)更新2月股份变动月报表,股本增至511,252,234股
北海康成-B03月04日获主力加仓271.2万元
市场透视 · 03-04
北海康成-B03月04日获主力加仓271.2万元
北海康成-B盘中异动 股价大跌5.24%
市场透视 · 03-03
北海康成-B盘中异动 股价大跌5.24%
北海康成-B盘中异动 股价大涨5.34%报2.960港元
市场透视 · 02-27
北海康成-B盘中异动 股价大涨5.34%报2.960港元
北海康成-B午后一度涨超6%
每日经济新闻 · 02-25
北海康成-B午后一度涨超6%
港股异动 | 北海康成-B(01228)午后涨超6% 拟向药明生物子公司配股 净筹约1.99亿港元
智通财经 · 02-25
港股异动 | 北海康成-B(01228)午后涨超6% 拟向药明生物子公司配股 净筹约1.99亿港元
北海康成-B盘中异动 早盘急速拉升5.30%
市场透视 · 02-25
北海康成-B盘中异动 早盘急速拉升5.30%
北海康成-B盘中异动 早盘股价大跌5.30%报2.860港元
市场透视 · 02-20
北海康成-B盘中异动 早盘股价大跌5.30%报2.860港元
港股异动 | 北海康成-B(01228)一度涨超17% 折让14.7%配股筹2亿港元 药明生物持股升至16.27%
智通财经网 · 02-16
港股异动 | 北海康成-B(01228)一度涨超17% 折让14.7%配股筹2亿港元 药明生物持股升至16.27%
北海康成-B(01228)拟折让约14.70%发行合共8403.36万股 净筹约1.99亿港元
智通财经 · 02-16
北海康成-B(01228)拟折让约14.70%发行合共8403.36万股 净筹约1.99亿港元
北海康成-B盘中异动 早盘股价大跌5.23%报2.720港元
市场透视 · 02-13
北海康成-B盘中异动 早盘股价大跌5.23%报2.720港元
北海康成-B盘中异动 股价大跌5.08%
市场透视 · 02-11
北海康成-B盘中异动 股价大跌5.08%
北海康成-B盘中异动 早盘股价大涨6.15%
市场透视 · 02-09
北海康成-B盘中异动 早盘股价大涨6.15%
北海康成-B盘中异动 股价大跌5.08%
市场透视 · 02-06
北海康成-B盘中异动 股价大跌5.08%
北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股
公告速递 · 02-05
北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股
北海康成-B盘中异动 股价大涨5.24%
市场透视 · 02-04
北海康成-B盘中异动 股价大涨5.24%
北海康成-B02月02日主力净流出65.9万元 散户资金买入
市场透视 · 02-02
北海康成-B02月02日主力净流出65.9万元 散户资金买入
加载更多
公司概况
公司名称:
北海康成-B
所属市场:
SEHK
上市日期:
--
主营业务:
CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合,其中包括三种获批药物和八种资产的管线,针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法,用于治疗II型粘多糖贮积症(MPS II),也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂,正在开发中,用于治疗罕见的胆汁淤积性肝病,包括Alagille综合征和进行性家族性肝内胆汁淤积症。
发行价格:
--
{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":2.66,"timestamp":1773994127036,"preClose":2.51,"halted":0,"volume":778000,"delay":0,"changeRate":0.05976095617529895,"floatShares":595000000,"shares":595000000,"eps":-1.041874,"marketStatus":"休市中","change":0.15,"latestTime":"03-20 16:08:47","open":2.54,"high":2.66,"low":2.5,"amount":1994040,"amplitude":0.063745,"askPrice":2.7,"askSize":49000,"bidPrice":2.66,"bidSize":183000,"shortable":0,"etf":0,"ttmEps":-0.251,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":2.51,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":1.1451280540474553,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"2619650261","title":"港股异动 | 北海康成-B(01228)午后涨超4% 公司完成向药明生物子公司配售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619650261","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619650261?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:42","pubTimestamp":1773384153,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,北海康成-B(01228)午后涨超4%,截至发稿,涨4%,报2.6港元,成交额159.38万港元。消息面上,北海康成完成发行合共8403.36万股认购股份。公司此前宣布,向药明生物旗下子公司配售股份。配售完成后,药明生物于北海康成的持股比例将升至约16.27%。公告称,配股事项所得款项净额约1.99亿港元,约12%将用于商业化产品的营运资金及注册维护;28%用于现有产品线的研发开支;60%用于结算集团的贸易应付款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320764599.SGD","LU3063872942.SGD","BK4585","LU0417516902.SGD","LU1242518931.SGD","BK1521","LU0359202008.SGD","LU0043850808.USD","LU0979878070.USD","LU0456827905.SGD","LU0516423091.SGD","LU2039709279.SGD","LU1242518857.USD","LU0327786744.USD","LU0307460666.USD","LU0516423174.USD","BK1576","LU0516422366.SGD","LU1880383366.USD","LU0052750758.USD","LU0572944931.SGD","01228","LU0359201612.USD","BK1161","LU0823426480.USD","LU0181495838.USD","VXUS","LU0348825331.USD","LU0417516738.SGD","LU1794554557.SGD","LU0456846285.SGD","LU0051755006.USD","BK1610","LU1688375341.USD","LU0348735423.USD","LU0039217434.USD","LU0516422952.EUR","LU0516422440.USD","SG9999002562.SGD","BK1141","LU0140636845.USD","LU0856984785.SGD","LU0823426308.USD","BK1589","IE00B0JY6N72.USD","LU0588546209.SGD","LU0819121731.USD","02269","LU0326950275.SGD","SG9999002463.SGD"],"gpt_icon":0},{"id":"2618962638","title":"北海康成-B(01228)完成发行合共8403.36万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2618962638","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618962638?lang=zh_cn&edition=full","pubTime":"2026-03-11 06:16","pubTimestamp":1773180970,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B(01228)发布公告,认购协议所载条件已获达成,并已根据认购协议的条款及条件于2026年3月10日完成交割。公司于交割日期以认购价每股认购股份2.38港元向认购人配发及发行合共8403.36万股认购股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2618664521","title":"北海康成-B盘中异动 大幅下跌6.99%报2.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618664521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618664521?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:40","pubTimestamp":1773020430,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时40分,北海康成-B股票出现异动,股价急速下跌6.99%。截至发稿,该股报2.530港元/股,成交量48.1万股,换手率0.09%,振幅5.88%。资金方面,该股资金流入37.151万港元,流出67.374万港元。北海康成-B股票所在的生物技术行业中,整体跌幅为3.19%。其相关个股中,科济药业-B、维立志博-B、愉悦集团涨幅较大,振幅较大的相关个股有科济药业-B、派格生物医药-B、维立志博-B,振幅分别为30.36%、15.64%、12.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403095458e84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909403095458e84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"1187944501","title":"北海康成-B(01228)更新2月股份变动月报表,股本增至511,252,234股","url":"https://stock-news.laohu8.com/highlight/detail?id=1187944501","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187944501?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:41","pubTimestamp":1772700100,"startTime":"0","endTime":"0","summary":"北海康成-B于2026年3月5日发布截至2026年2月28日的股份变动月报表。公司法定股本保持在5,000,000,000股,面值每股0.00001美元,总额50,000美元,本月并无变动。本月公司已发行股份由上月底的511,222,234股增至511,252,234股,新增30,000股,均由行使首次公开发售后购股权计划产生,合计募集资金约80,400港元。截至报告期末,公司已发行股份总数为511,252,234股,公众持股量符合香港联交所相关规定。公司表示将继续遵守香港联交所《上市规则》等相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2617592355","title":"北海康成-B03月04日获主力加仓271.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617592355?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612135,"startTime":"0","endTime":"0","summary":"03月04日, 北海康成-B股价涨1.48%,报收2.74元,成交金额500.9万元,换手率0.37%,振幅3.33%,量比1.07。北海康成-B今日主力资金净流入271.2万元,上一交易日主力净流入54万元。该股近5个交易日下跌1.79%,主力资金累计净流入435.1万元;近20日主力资金累计净流入830.8万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161726a6a13bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161726a6a13bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2616879397","title":"北海康成-B盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616879397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616879397?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:45","pubTimestamp":1772502358,"startTime":"0","endTime":"0","summary":"2026年03月03日早盘09时45分,北海康成-B股票出现波动,股价大幅跳水5.24%。截至发稿,该股报2.710港元/股,成交量16.7万股,换手率0.03%,振幅2.45%。资金方面,该股资金流入0港元,流出45.671万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体涨幅为0.67%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030309455897a7bb1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030309455897a7bb1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2614316998","title":"北海康成-B盘中异动 股价大涨5.34%报2.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614316998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614316998?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:46","pubTimestamp":1772156797,"startTime":"0","endTime":"0","summary":"2026年02月27日早盘09时46分,北海康成-B股票出现波动,股价急速上涨5.34%。截至发稿,该股报2.960港元/股,成交量14.4万股,换手率0.03%,振幅2.85%。资金方面,该股资金流入16.211万港元,流出23.405万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体涨幅为0.48%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709463795422c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022709463795422c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2614708649","title":"北海康成-B午后一度涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614708649","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614708649?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:53","pubTimestamp":1772002422,"startTime":"0","endTime":"0","summary":"每经AI快讯,北海康成-B(01228.HK)午后一度涨超6%,截至发稿涨5.68%,报2.79港元,成交额172.27万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602253653975683.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602253653975683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2614770941","title":"港股异动 | 北海康成-B(01228)午后涨超6% 拟向药明生物子公司配股 净筹约1.99亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614770941","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614770941?lang=zh_cn&edition=full","pubTime":"2026-02-25 14:36","pubTimestamp":1772001366,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,北海康成-B(01228)午后涨超6%,截至发稿,涨5.68%,报2.79港元,成交额172.27万港元。消息面上,北海康成此前宣布,向药明生物旗下子公司配售8,403.36万股股份,占扩大后股本约14.12%。配股事项所得款项净额约1.99亿港元,约12%将用于商业化产品的营运资金及注册维护;28%用于现有产品线的研发开支;60%用于结算集团的贸易应付款项。配售完成后,药明生物于北海康成的持股比例将升至约16.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999002463.SGD","LU0348825331.USD","LU1720050803.USD","LU1794554557.SGD","LU1688375341.USD","SG9999002562.SGD","VT","LU0516422366.SGD","LU0979878070.USD","02269","BK1521","BK4588","LU0516422952.EUR","LU0359202008.SGD","LU0140636845.USD","BK1141","IE00B0JY6N72.USD","LU0307460666.USD","LU0039217434.USD","LU0326950275.SGD","LU0348735423.USD","BK1161","LU0417516902.SGD","LU0572944931.SGD","LU0823426480.USD","BK1576","01228","BK4585","LU0516422440.USD","BK1589","LU0456846285.SGD","LU0823426308.USD","LU2039709279.SGD","LU0456827905.SGD","LU0320764599.SGD","LU0181495838.USD","LU1242518931.SGD","LU0043850808.USD","LU1242518857.USD","LU1880383366.USD","LU0588546209.SGD","LU0052750758.USD","LU0359201612.USD","BK1610","LU0856984785.SGD","VXUS","LU0516423174.USD","LU0051755006.USD","LU0327786744.USD","LU0417516738.SGD"],"gpt_icon":0},{"id":"2614086494","title":"北海康成-B盘中异动 早盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614086494?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:47","pubTimestamp":1771984056,"startTime":"0","endTime":"0","summary":"2026年02月25日早盘09时47分,北海康成-B股票出现异动,股价快速上涨5.30%。截至发稿,该股报2.780港元/股,成交量5.7万股,换手率0.01%,振幅5.30%。北海康成-B股票所在的生物技术行业中,整体跌幅为0.53%。其相关个股中,北海康成-B、翰思艾泰-B、创胜集团-B涨幅较大,振幅较大的相关个股有云康集团、帝王国际投资、百奥赛图-B,振幅分别为8.75%、8.55%、6.78%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225094736a4c505d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225094736a4c505d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2613927732","title":"北海康成-B盘中异动 早盘股价大跌5.30%报2.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613927732?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:25","pubTimestamp":1771554322,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘10时25分,北海康成-B股票出现波动,股价大幅下跌5.30%。截至发稿,该股报2.860港元/股,成交量40.9万股,换手率0.08%,振幅4.64%。资金方面,该股资金流入32.32万港元,流出40.073万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体涨幅为1.86%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220102522a70bf2c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220102522a70bf2c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2611517054","title":"港股异动 | 北海康成-B(01228)一度涨超17% 折让14.7%配股筹2亿港元 药明生物持股升至16.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611517054","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611517054?lang=zh_cn&edition=full","pubTime":"2026-02-16 11:05","pubTimestamp":1771211131,"startTime":"0","endTime":"0","summary":"北海康成-B(01228)今早一度涨超17%,截至发稿,涨8.6%,报3.03港元,成交额2664.84万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260216/20260216110554_67095.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260216/20260216110554_67095.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SG9999002463.SGD","LU0348825331.USD","LU1720050803.USD","LU1794554557.SGD","LU1688375341.USD","VT","LU0708995583.HKD","LU0516422366.SGD","LU0979878070.USD","02269","BK1521","BK4588","LU0516422952.EUR","LU3063872942.SGD","LU0140636845.USD","BK1141","IE00B0JY6N72.USD","LU0307460666.USD","LU0039217434.USD","LU0326950275.SGD","LU0348735423.USD","BK1161","LU0417516902.SGD","LU0572944931.SGD","LU0823426480.USD","BK1576","01228","LU0516422440.USD","BK1589","LU0456846285.SGD","LU0823426308.USD","LU2039709279.SGD","LU0320764599.SGD","LU0516423091.SGD","LU0181495838.USD","LU0819121731.USD","LU0043850808.USD","LU1242518931.SGD","LU1242518857.USD","LU1880383366.USD","LU0588546209.SGD","LU0052750758.USD","LU0359201612.USD","BK1610","LU0856984785.SGD","VXUS","LU0516423174.USD","LU0051755006.USD","LU0327786744.USD","LU0417516738.SGD"],"gpt_icon":0},{"id":"2611176702","title":"北海康成-B(01228)拟折让约14.70%发行合共8403.36万股 净筹约1.99亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611176702","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611176702?lang=zh_cn&edition=full","pubTime":"2026-02-16 06:24","pubTimestamp":1771194299,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B 发布公告,于2026年2月15日,本公司与认购人订立认购协议,据此,本公司已有条件同意发行及认购人已有条件同意认购合共8403.36万股认购股份,认购价为每股认购股份2.38港元。每股认购股份2.38港元的认购价较股份于2026年2月13日在联交所所报的收市价每股2.79港元折让约14.70%。认购事项所得款项总额将约为2亿港元,及经扣除就认购事项产生的相关开支后,本公司根据认购事项应收所得款项净额估计约为1.99亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2611183914","title":"北海康成-B盘中异动 早盘股价大跌5.23%报2.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611183914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611183914?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:05","pubTimestamp":1770948335,"startTime":"0","endTime":"0","summary":"2026年02月13日早盘10时05分,北海康成-B股票出现异动,股价快速跳水5.23%。截至发稿,该股报2.720港元/股,成交量122.9万股,换手率0.24%,振幅9.06%。资金方面,该股资金流入220.214万港元,流出111.636万港元。北海康成-B股票所在的生物技术行业中,整体跌幅为1.16%。其相关个股中,科笛-B、维升药业-B、荃信生物-B涨幅较大,振幅较大的相关个股有北海康成-B、荃信生物-B、轩竹生物-B,振幅分别为9.06%、7.37%、6.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131005359540f86e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131005359540f86e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2610853579","title":"北海康成-B盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610853579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610853579?lang=zh_cn&edition=full","pubTime":"2026-02-11 10:11","pubTimestamp":1770775904,"startTime":"0","endTime":"0","summary":"2026年02月11日早盘10时11分,北海康成-B股票出现异动,股价大幅下挫5.08%。截至发稿,该股报2.990港元/股,成交量166.9万股,换手率0.33%,振幅8.25%。北海康成-B股票所在的生物技术行业中,整体涨幅为1.90%。其相关个股中,歌礼制药-B、基石药业-B、映恩生物-B涨幅较大,振幅较大的相关个股有MIRXES-B、北海康成-B、旺山旺水-B,振幅分别为17.96%、8.25%、7.12%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211101144a495d535&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211101144a495d535&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2610507706","title":"北海康成-B盘中异动 早盘股价大涨6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610507706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610507706?lang=zh_cn&edition=full","pubTime":"2026-02-09 09:38","pubTimestamp":1770601121,"startTime":"0","endTime":"0","summary":"2026年02月09日早盘09时38分,北海康成-B股票出现异动,股价急速拉升6.15%。截至发稿,该股报3.280港元/股,成交量30.6万股,换手率0.06%,振幅7.44%。北海康成-B股票所在的生物技术行业中,整体涨幅为2.23%。其相关个股中,奥星生命科技、歌礼制药-B、映恩生物-B涨幅较大,振幅较大的相关个股有歌礼制药-B、北海康成-B、映恩生物-B,振幅分别为7.63%、7.44%、6.92%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020909384195405938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020909384195405938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2609514854","title":"北海康成-B盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609514854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609514854?lang=zh_cn&edition=full","pubTime":"2026-02-06 15:16","pubTimestamp":1770362184,"startTime":"0","endTime":"0","summary":"2026年02月06日下午盘15时16分,北海康成-B股票出现波动,股价急速下跌5.08%。截至发稿,该股报2.990港元/股,成交量780.2万股,换手率1.53%,振幅8.89%。资金方面,该股资金流入1486.12万港元,流出783.703万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体跌幅为0.12%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020615162497a52855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020615162497a52855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"1131459471","title":"北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1131459471","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131459471?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:38","pubTimestamp":1770284319,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年2月5日发布2026年1月股份变动月报表。报告期覆盖2026年1月1日至1月31日。已发行股份由期初的511,120,234股增至期末的511,222,234股,本月内新增发行为102,000股,主要来源于首次公开发售后购股权计划的行使。根据公告,本月在行使期权方面,股东大会曾于2024年6月27日批准的购股权计划产生102,000股新股发行。公司确认截至2026年1月31日已符合香港联交所的最低公众持股量要求,股权结构保持畅通。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2608033126","title":"北海康成-B盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608033126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608033126?lang=zh_cn&edition=full","pubTime":"2026-02-04 11:14","pubTimestamp":1770174893,"startTime":"0","endTime":"0","summary":"2026年02月04日早盘11时14分,北海康成-B股票出现异动,股价快速拉升5.24%。截至发稿,该股报2.810港元/股,成交量403.955万股,换手率0.79%,振幅4.12%。北海康成-B股票所在的生物技术行业中,整体跌幅为0.79%。其相关个股中,帝王国际投资、轩竹生物-B、北海康成-B涨幅较大,振幅较大的相关个股有帝王国际投资、圣诺医药-B、奥星生命科技,振幅分别为18.02%、11.93%、11.90%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204111453a6d0ebfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204111453a6d0ebfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2608813783","title":"北海康成-B02月02日主力净流出65.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608813783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608813783?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020146,"startTime":"0","endTime":"0","summary":"02月02日, 北海康成-B股价跌3.24%,报收2.69元,成交金额502.4万元,换手率0.36%,振幅4.32%,量比0.28。北海康成-B今日主力资金净流出65.9万元,上一交易日主力净流入73.3万元。该股近5个交易日下跌1.10%,主力资金累计净流出45.6万元;近20日主力资金累计净流入461.7万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162056a4727d04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162056a4727d04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":0.027},{"period":"1month","weight":-0.1192},{"period":"3month","weight":0.3854},{"period":"6month","weight":0.0472},{"period":"1year","weight":17.2192},{"period":"ytd","weight":0.0391}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合,其中包括三种获批药物和八种资产的管线,针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法,用于治疗II型粘多糖贮积症(MPS II),也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂,正在开发中,用于治疗罕见的胆汁淤积性肝病,包括Alagille综合征和进行性家族性肝内胆汁淤积症。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.126185},{"month":2,"riseRate":0.4,"avgChangeRate":0.011895},{"month":3,"riseRate":0.2,"avgChangeRate":-0.102747},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006446},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.547002},{"month":8,"riseRate":0.25,"avgChangeRate":0.239858},{"month":9,"riseRate":0.75,"avgChangeRate":0.161514},{"month":10,"riseRate":0,"avgChangeRate":-0.161874},{"month":11,"riseRate":0.25,"avgChangeRate":-0.205763},{"month":12,"riseRate":0.5,"avgChangeRate":0.059277}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}